AMATERA

Amatera Biosciences is a French biotechnology company that has developed a proprietary, non-GMO breeding platform designed to accelerate the development of climate-resilient perennial crops. By integrating advanced plant cell biology, high-throughput automation, and machine learning, the company shifts the traditional crop screening process from greenhouse environments to the cellular level. This approach allows them to identify and develop improved genetic traits significantly faster and more cost-effectively than conventional breeding methods, which can otherwise take decades for perennial plants. Their platform focuses on optimizing variety improvement through in vitro culture techniques, enabling the rapid selection and crossing of plants to address threats like disease and climate change.

The company’s work is critical for partners in the seed and agrifood industries who face the urgent need to sustain global crop production in the face of environmental challenges. Amatera is currently working on specific high-impact projects, including the development of a climate-resistant coffee variety dubbed Robustica, which aims to combine the quality of Arabica with the robustness of Robusta, as well as a naturally caffeine-free coffee bean. Beyond coffee, they are applying their technology to other essential crops such as grapes, aiming to reduce pesticide dependence. Headquartered in Paris and founded in 2022, Amatera has attracted significant venture investment to scale its automated genetics platform and industrialize its R&D capabilities for a broader range of perennial and annual crops.